I-Mab Biopharma
IMAB
$1.80
Share price
0.00%
Change (1 day)
-43.40%
Change (1 year)
Categories
Revenue for I-Mab Biopharma (IMAB)
Revenue in 2020 (TTM): $0.23 B
According to I-Mab Biopharma's latest financial reports the company's current revenue (TTM) is $0.23 B. In 2022 the company made a revenue of -$32.13 M a decrease over the years 2021 revenue that were of $13.81 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for I-Mab Biopharma from 2017 to 2020
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 | -$32.13 M | -332.55% |
| 2021 | $13.81 M | -94.16% |
| 2020 | $0.23 B | 5407.66% |
| 2019 | $4.29 M | -45.08% |
| 2018 | $7.82 M | 340.25% |
| 2017 | $1.77 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.86 B | 261.85% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $0.22 M | -99.91% | 🇺🇸 USA |